Operating Lease, Right-of-Use Asset of Aurinia Pharmaceuticals Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aurinia Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Aurinia Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,718,000, a 11% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Aurinia Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,718,000 -$461,000 -11% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $3,837,000 -$451,000 -11% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $3,954,000 -$440,000 -10% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $4,068,000 -$430,000 -9.6% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $4,179,000 -$430,000 -9.3% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $4,288,000 -$426,000 -9% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $4,394,000 -$419,000 -8.7% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $4,498,000 -$409,000 -8.3% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $4,609,000 -$336,000 -6.8% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $4,714,000 -$365,000 -7.2% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $4,813,000 -$419,000 -8% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $4,907,000 -$476,000 -8.8% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 $4,945,000 -$587,000 -11% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $5,079,000 -$536,000 -9.5% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $5,232,000 -$529,000 -9.2% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $5,383,000 -$106,000 -1.9% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $5,532,000 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $5,615,000 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $5,761,000 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $5,489,000 +$5,489,000 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q4 2019 $0 31 Dec 2019 10-K 24 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.